Related Experiment Video
Updated: Apr 17, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9
Tong Han1, Xiao-Ping Yi2, Bo Liu3
1Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Abstract:
MicroRNAs (miRNAs) represent a class of small non‑coding RNAs regulating gene expression by inducing the degradation of RNA or interfering with translation. Aberrant miRNA expression has been described in several types of cancer in humans. In the present study, it was demonstrated that miR‑145 is downregulated in pancreatic cancer tissues and the Panc‑1 cell line. Restoration of miR‑145 inhibited cell proliferation, invasion and migration in Panc‑1 cells. Neural precursor cell expressed, developmentally down‑regulated 9 (NEDD9) has been identified as a novel potential miR‑145 target using bioinformatics. Using luciferase reporter constructs, it was observed that the NEDD9 3'‑untranslated region is the location of the direct binding site for miR‑145. Additionally, it was identified that miR‑145 is inversely correlated with NEDD9 expression in pancreatic cancer tissues and that restoration of miR‑145 in Panc‑1 cells reduced NEDD9 mRNA and protein expression accompanied by inhibition of cell proliferation, invasion and migration. In conclusion, these findings indicate that miR‑145 may be an effective target for pancreatic cancer therapy.
Insights
MicroRNA-145 (miR-145) is downregulated in pancreatic cancer, inhibiting tumor cell proliferation and migration. Restoring miR-145 reduces NEDD9 expression, suggesting its therapeutic potential for pancreatic cancer.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
- Aberrant miRNA expression is linked to human cancers.
- Pancreatic cancer is a significant health concern with complex molecular underpinnings.
Purpose of the Study:
- To investigate the role of miR-145 in pancreatic cancer.
- To identify potential targets of miR-145 in pancreatic cancer cells.
- To evaluate the therapeutic potential of miR-145 restoration in pancreatic cancer.
Main Methods:
- Quantitative real-time PCR to assess miR-145 expression.
- Cell proliferation, invasion, and migration assays.
- Bioinformatic analysis and luciferase reporter assays to identify and validate miR-145 targets.
- Western blot and qRT-PCR to measure target gene expression.
Main Results:
- miR-145 was significantly downregulated in pancreatic cancer tissues and cell lines.
- Restoration of miR-145 inhibited pancreatic cancer cell proliferation, invasion, and migration.
- NEDD9 was identified as a direct target of miR-145, with inverse correlation in patient tissues.
- miR-145 restoration reduced NEDD9 mRNA and protein levels in cancer cells.
Conclusions:
- miR-145 plays a tumor-suppressive role in pancreatic cancer.
- The miR-145/NEDD9 axis is a critical regulator of pancreatic cancer progression.
- miR-145 represents a promising therapeutic target for pancreatic cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

